In silico gene-to-drug discovery

摘要

Although advances in high-throughput screening in proteomics and genomics have produced abundant disease-related protein targets, the ability to identify effective drug candidates lags. Virtual probing of biological targets with chemical libraries can computationally identify drug leads, but this approach has been limited by insufficient information on detailed protein structure and computational power.